Erratum: Soluble B and T lymphocyte attenuator possesses antitumor effects and facilitates heat shock protein 70 vaccine-triggered antitumor immunity against a murine TC-1 cervical cancer model in vivo (Journal of Immunology (2009) 183 (7842-7850) DOI: 10.4049/jimmunol.0804379);Soluble B and T lymphocyte attenuator possesses antitumor effects and facilitates heat shock protein 70 vaccine-triggered antitumor immunity against a murine TC-1 cervical cancer model in vivo

Journal of Immunology

Volumn 183, Issue 12, 2009, Pages 7842-7850

  Han, Lingfei ^a,c   Wang, Wei ^a   Fang, Yong ^a   Feng, Zuohua ^b   Liao, Shujie ^a   Li, Wei ^a   Li, Yan ^a   Li, Chunxiao ^a   Maitituoheti, Mayinuer ^a   Dong, Hong ^a   Lai, Zhiwen ^a   Gao, Qinglei ^a   Xi, Ling ^a   Wu, Mingfu ^a   Wang, Daowen ^a   Zhou, Jianfeng ^a   Meng, Li ^a   Wang, Shixuan ^a   Ma, Ding ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^b HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^c TONGJI UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

B7 ANTIGEN; GAMMA INTERFERON; HEAT SHOCK PROTEIN 70; HERPESVIRUS ENTRY MEDIATOR; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 2; PLASMID SOLUBLE B LYMPHOCYTE T LYMPHOCYTE ATTENUATOR; PLASMID VECTOR; TRANSCRIPTION FACTOR FOXP3; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG; BTLA PROTEIN, MOUSE; DNA VACCINE; IMMUNOGLOBULIN RECEPTOR; TNFRSF14 PROTEIN, MOUSE;

ANIMAL CELL; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER IMMUNIZATION; CELL FUNCTION; CONTROLLED STUDY; DENDRITIC CELL; DOWN REGULATION; FEMALE; IN VIVO STUDY; MOUSE; NONHUMAN; PRIORITY JOURNAL; TH1 CELL; TUMOR IMMUNITY; UTERINE CERVIX CANCER; ANIMAL; B LYMPHOCYTE; CHO CELL; CRICETULUS; DISEASE MODEL; DRUG ANTAGONISM; EXPERIMENTAL MELANOMA; EXTRACELLULAR SPACE; GENETICS; HAMSTER; IMMUNOLOGY; METABOLISM; PHYSIOLOGY; PROTEIN TERTIARY STRUCTURE; SIGNAL TRANSDUCTION; T LYMPHOCYTE SUBPOPULATION; TUMOR CELL LINE; UTERINE CERVIX TUMOR;

ANIMALS; B-LYMPHOCYTE SUBSETS; CELL LINE, TUMOR; CHO CELLS; CRICETINAE; CRICETULUS; DISEASE MODELS, ANIMAL; EXTRACELLULAR SPACE; FEMALE; HSP70 HEAT-SHOCK PROTEINS; MELANOMA, EXPERIMENTAL; MICE; PROTEIN STRUCTURE, TERTIARY; RECEPTORS, IMMUNOLOGIC; RECEPTORS, TUMOR NECROSIS FACTOR, MEMBER 14; SIGNAL TRANSDUCTION; T-LYMPHOCYTE SUBSETS; UTERINE CERVICAL NEOPLASMS; VACCINES, DNA;

EID: 76249106207     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1901449     Document Type: Erratum

References (36)

1. Watanabe, N., M. Gavrieli, J. R. Sedy, J. Yang, F. Fallarino, S. K. Loftin, M. A. Hurchla, N. Zimmerman, J. Sim, X. Zang, et al. 2003. BTLA is a lymphocyte inhibitory receptor with similarities to CTLA-4 and PD-1. Nat. Immunol. 4: 670-679.
2. Croft, M. 2005. The evolving crosstalk between co-stimulatory and co-inhibitory receptors: HVEM-BTLA. Trends Immunol. 26: 292-294. (Pubitemid 40732659)
3. Sedy, J. R., M. Gavrieli, K. G. Potter, M. A. Hurchla, R. C. Lindsley, K. Hildner, S. Scheu, K. Pfeffer, C. F. Ware, T. L. Murphy, and K. M. Murphy. 2005. B and T lymphocyte attenuator regulates T cell activation through interaction with herpesvirus entry mediator. Nat. Immunol. 6: 90-98. (Pubitemid 40136700)
4. Han, P., O. D. Goularte, K. Rufner, B. Wilkinson, and J. Kaye. 2004. An inhibitory Ig superfamily protein expressed by lymphocytes and APCs is also an early marker of thymocyte positive selection. J. Immunol. 172: 5931-5939. (Pubitemid 38621192)
5. Gonzalez, L. C., K. M. Loyet, J. Calemine-Fenaux, V. Chauhan, B. Wranik, W. Ouyang, and D. L. Eaton. 2005. A coreceptor interaction between the CD28 and TNF receptor family members B and T lymphocyte attenuator and herpesvirus entry mediator. Proc. Natl. Acad. Sci. USA 102: 1116-1121.
6. Murphy, K. M., C. A. Nelson, and J. R. Sedy. 2006. Balancing co-stimulation and inhibition with BTLA and HVEM. Nat. Rev. Immunol. 6: 671-681. (Pubitemid 44298216)
7. Gavrieli, M., N. Watanabe, S. K. Loftin, T. L. Murphy, and K. M. Murphy. 2003. Characterization of phosphotyrosine binding motifs in the cytoplasmic domain of B and T lymphocyte attenuator required for association with protein tyrosine phosphatases SHP-1 and SHP-2. Biochem. Biophys. Res. Commun. 312: 1236-1243. (Pubitemid 37490949)
8. Lasaro, M. O., N. Tatsis, S. E. Hensley, J. C. Whitbeck, S. W. Lin, J. J. Rux, E. J. Wherry, G. H. Cohen, R. J. Eisenberg, and H. C. Ertl. 2008. Targeting of antigen to the herpesvirus entry mediator augments primary adaptive immune responses. Nat. Med. 14: 205-212.
9. Li, J., Z. X. Ye, K. N. Li, J. H. Cui, J. Li, Y. X. Cao, Y. F. Liu, and S. J. Yang. 2007. HSP70 gene fused with Hantavirus S segment DNA significantly enhances the DNA vaccine potency against hantaviral nucleocapsid protein in vivo. Vaccine 25: 239-252. (Pubitemid 44856081)
10. Lan, Y. H., Y. G. Li, Z. W. Liang, M. Chen, M. L. Peng, L. Tang, H. D. Hu, and H. Ren. 2007. A DNA vaccine against chimeric AFP enhanced by HSP70 suppresses growth of hepatocellular carcinoma. Cancer Immunol. Immunother. 56: 1009-1016.
11. Ge, F. F., Y. F. Qiu, Y. W. Yang, and P. Y. Chen. 2007. An hsp70 fusion protein vaccine potentiates the immune response against Japanese encephalitis virus. Arch. Virol. 152: 125-135. (Pubitemid 44974620)
12. Nelson, C. A., M. D. Fremont, J. R. Sedy, P. S. Norris, C. F. Ware, K. M. Murphy, and D. H. Fremont. 2008. Structural determinants of herpesvirus entry mediator recognition by murine B and T lymphocyte attenuator. J. Immunol. 180: 940-947.
13. Geng, H., G. M. Zhang, D. Li, H. Zhang, Y. Yuan, H. G. Zhu, H. Xiao, L. F. Han, and Z. H. Feng. 2006. Soluble form of T cell Ig mucin 3 is an inhibitory molecule in T cell-mediated immune response. J. Immunol. 176: 1411-1420. (Pubitemid 43134283)
14. He, Y. F., G. M. Zhang, X. H. Wang, H. Zhang, Y. Yuan, D. Li, and Z. H. Feng. 2004. Blocking programmed death-1 ligand-PD-1 interactions by local gene therapy results in enhancement of antitumor effect of secondary lymphoid tissue chemokine. J. Immunol. 173: 4919-4928.
15. Geng, H., G. M. Zhang, H. Xiao, Y. Yuan, D. Li, H. Zhang, H. Qiu, Y. F. He, and Z. H. Feng. 2006. HSP70 vaccine in combination with gene therapy with plasmid DNA encoding sPD-1 overcomes immune resistance and suppresses the progression of pulmonary metastatic melanoma. Int. J. Cancer 118: 2657-2664. (Pubitemid 43673341)
16. Xiao, H., B. Huang, Y. Yuan, D. Li, L. F. Han, Y. Liu, W. Gong, F. H. Wu, G. M. Zhang, and Z. H. Feng. 2007. Soluble PD-1 facilitates 4-1BBL-triggered antitumor immunity against murine H22 hepatocarcinoma in vivo. Clin. Cancer Res. 13: 1823-1830. (Pubitemid 46952952)
17. De Trez, C., K. Schneider, K. Potter, N. Droin, J. Fulton, P. S. Norris, S. W. Ha, Y. X. Fu, T. Murphy, K. M. Murphy, et al. 2008. The inhibitory HVEM-BTLA pathway counter regulates lymphotoxin receptor signaling to achieve homeostasis of dendritic cells. J. Immunol. 180: 238-248.
18. De Trez, C., and C. F. Ware. 2008. The TNF receptor and Ig superfamily members form an integrated signaling circuit controlling dendritic cell homeostasis. Cytokine Growth Factor Rev. 19: 277-284.
19. + T cell-intrinsic homeostasis and memory cell generation. Nat. Immunol. 8: 162-171.
20. Yi, K. H., H. Nechushtan, W. J. Bowers, G. R. Walker, Y. Zhang, D. G. Pham, E. R. Podack, H. J. Federoff, K. A. Tolba, and J. D. Rosenblatt. 2007. Adoptively transferred tumor-specific T cells stimulated ex vivo using herpes simplex virus amplicons encoding 4-1BBL persist in the host and show antitumor activity in vivo. Cancer Res. 67: 10027-10037.
21. Stephan, M. T., V. Ponomarev, R. J. Brentjens, A. H. Chang, K. V. Dobrenkov, G. Heller, and M. Sadelain. 2007. T cell-encoded CD80 and 4-1BBL induce autoand transcostimulation, resulting in potent tumor rejection. Nat. Med. 13: 1440-1449.
22. Yamamoto, R., M. Nishikori, T. Kitawaki, T. Sakai, M. Hishizawa, M. Tashima, T. Kondo, K. Ohmori, M. Kurata, T. Hayashi, and T. Uchiyama. 2008. PD-1-PD-1 ligand interaction contributes to immunosuppressive microenvironment of Hodgkin lymphoma. Blood 111: 3220-3224.
23. Zeng, R., Z. Zhang, X. Mei, W. Gong, and L. Wei. 2008. Protective effect of a RSV subunit vaccine candidate G1F/M2 was enhanced by a HSP70-like protein in mice. Biochem. Biophys. Res. Commun. 377: 495-499.
24. Timke, C., H. Zieher, A. Roth, K. Hauser, K. E. Lipson, K. J. Weber, J. Debus, A. Abdollahi, and P. E. Huber. 2008. Combination of vascular endothelial growth factor receptor/platelet-derived growth factor receptor inhibition markedly improves radiation tumor therapy. Clin. Cancer Res. 14: 2210-2219. (Pubitemid 351551134)
25. + T cells after intratumoral Ad5-TRAIL/CpG oligodeoxynucleotide combination therapy. Cancer Res. 67: 11980-11990.
26. Dorrell, M. I., E. Aguilar, L. Scheppke, F. H. Barnett, and M. Friedlander. 2007. Combination angiostatic therapy completely inhibits ocular and tumor angiogenesis. Proc. Natl. Acad. Sci. USA 104: 967-972.
27. Savai, R., R. T. Schermuly, S. S. Pullamsetti, M. Schneider, S. Greschus, H. A. Ghofrani, H. Traupe, F. Grimminger, and G. A. Banat. 2007. A combination hybrid-based vaccination/adoptive cellular therapy to prevent tumor growth by involvement of T cells. Cancer Res. 67: 5443-5453. (Pubitemid 46997285)
28. Kurotaki, T., Y. Tamura, G. Ueda, J. Oura, G. Kutomi, Y. Hirohashi, H. Sahara, T. Torigoe, H. Hiratsuka, H. Sunakawa, et al. 2007. Efficient cross-presentation by heat shock protein 90-peptide complex-loaded dendritic cells via an endosomal pathway. J. Immunol. 179: 1803-1813.
29. Enomoto, Y., A. Bharti, A. A. Khaleque, B. Song, C. Liu, V. Apostolopoulos, P. X. Xing, S. K. Calderwood, and J. Gong. 2006. Enhanced immunogenicity of heat shock protein 70 peptide complexes from dendritic cell-tumor fusion cells. J. Immunol. 177: 5946-5955. (Pubitemid 44628808)
30. Srivastava, P. 2002. Interaction of heat shock proteins with peptides and antigen presenting cells: chaperoning of the innate and adaptive immune responses. Annu. Rev. Immunol. 20: 395-425. (Pubitemid 34293430)
31. Liu, B., A. M. DeFilippo, and Z. Li. 2002. Overcoming immune tolerance to cancer by heat shock protein vaccines. Mol. Cancer Ther. 1: 1147-1151.
32. Hori, S., T. Nomura, and S. Sakaguchi. 2003. Control of regulatory T cell development by the transcription factor Foxp3. Science 299: 1057-1061. (Pubitemid 36222930)
33. Williams, L. M., and A. Y. Rudensky. 2007. Maintenance of the Foxp3-dependent developmental program in mature regulatory T cells requires continued expression of Foxp3. Nat. Immunol. 8: 277-284.
34. + regulatory T cells. Nat. Immunol. 4: 330-336.
35. Tao, R., L. Wang, K. M. Murphy, C. C. Fraser, and W. W. Hancock. 2008. Regulatory T cell expression of herpesvirus entry mediator suppresses the function of B and T lymphocyte attenuator-positive effector T cells. J. Immunol. 180: 6649-6655.
36. + T cells. Nat. Immunol. 9: 122-124.